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Summary
Recent evidence suggests that human cells require more genetic changes for neoplastic transformation than do their
murine counterparts. However, a precise enumeration of these differences has never been undertaken. We have determined
that perturbation of two signaling pathways—involving p53 and Raf—suffices for the tumorigenic conversion of normal
murine fibroblasts, while perturbation of six pathways—involving p53, pRb, PP2A, telomerase, Raf, and Ral-GEFs—is
needed for human fibroblasts. Cell type-specific differences also exist in the requirements for tumorigenic transformation:
immortalized human fibroblasts require the activation of Raf and Ral-GEFs, human embryonic kidney cells require the
activation of PI3K and Ral-GEFs, and human mammary epithelial cells require the activation of Raf, PI3K, and Ral-GEFs.
Introduction human cell types to undergo transformation to a tumorigenic
state (Hahn et al., 1999; Hahn and Weinberg, 2002b). These
observations further substantiated that human cell transforma-Much of our current understanding of how cell transformation
occurs in human tissues derives from studies undertaken in tion requires perturbation of several additional pathways beyond
those required for murine cell transformation.rodent cells. However, emerging evidence has begun to indicate
fundamental differences in the behavior of rodent and human We subsequently demonstrated that the functions of SV40
LT oncoprotein in these experiments can be phenocopied bycells, specifically in certain biological traits relevant to the trans-
formation process. For example, whereas prolonged culturing using a dominant-negative oligomerization mutant of p53 and
an INK4a-resistant mutant of CDK4 plus overexpressed cyclinof mouse embryonic fibroblasts (MEFs) under regular culture
conditions results in their spontaneous immortalization, compa- D1 (Hahn et al., 2002). More recently, short-interfering (si)RNA-
mediated suppression of p53 and pRb has been shown to re-rable treatment of human fibroblasts leads instead to replicative
quiescence. Furthermore, introduction of combinations of onco- place LT in similar experiments (Voorhoeve and Agami, 2003).
Taken together, these data indicate that LT contributes to exper-genes such as E1ARas or mycRas readily induces transfor-
mation of primary rodent cells, while introduction of the same imental human cell transformation primarily through its actions
on p53 and pRb. The precise mechanistic functions of the SV40combination of oncogenes fails to transform primary human
cells (Hahn and Weinberg, 2002a; Rangarajan and Weinberg, ST oncoprotein in this process have remained unclear. However,
it has been shown very recently that the ST oncoprotein may2003). These observations indicated that mouse and human
cells indeed have quite distinct requirements for cellular trans- exert its oncogenic potential by preventing dephosphorylation
of c-Myc, thereby resulting in c-Myc stabilization (Yeh et al.,formation.
We have previously found that the introduction of three 2004).
Signaling by the Ras oncoprotein itself activates multiplegenetic elements—specifically, the SV40-early region (encoding
both the LT and small T antigens, which together inactivate p53, downstream signaling pathways (Campbell et al., 1998), and
differing requirements for the activation of these Ras “effector”pRb, and some activities of protein phosphatase 2A), a gene
encoding the hTERT catalytic subunit of the human telomerase pathways have also been reported (Shields et al., 2000). More
specifically, the three major Ras-downstream effectors knownholoenzyme (which helps to maintain the telomeric ends), and
a gene specifying an oncogenic allele of Ras (which provides to have important functions in Ras-mediated transformation are
Raf, PI3K, and the Ral guanine nucleotide exchange factorsboth mitogenic and survival signals)—causes a variety of normal
S I G N I F I C A N C E
Substantial differences exist in the requirements for the transformation of rodent cells compared to human cells. The 6 changes
required for the experimental transformation of cultured human fibroblasts, when compared with the 2 required by mouse fibroblasts,
as described here, are likely to be reflected in the complexities of multistep tumor progression in the two species. This, in turn, may
affect the ability of certain rodent models of carcinogenesis to accurately mimic tumorigenesis in humans. Furthermore, the differing
requirements for transformation of different human cell types—fibroblasts, embryonic kidney cells, and mammary epithelial cells—
suggests that their intrinsic biological differences must be taken into account when attempting to extrapolate transformation mecha-
nisms of one cell type to those governing others.
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(Ral-GEFs) (Shields et al., 2000). While sole activation of the months) without generating any spontaneously immortalized
clones.Raf pathway has been shown to suffice for Ras-mediated trans-
Since introduction of the gene encoding the catalytic subunitformation of NIH3T3 immortalized mouse fibroblasts (Campbell
of human telomerase (hTERT) into presenescent human BJ der-et al., 1998; Rodriguez-Viciana et al., 1997), activation of this
mal fibroblasts has been shown to bypass replicative senes-pathway alone did not transform immortalized human BJ fibro-
cence and cause immortalization (Vaziri and Benchimol, 1998),blasts, MCF-10A human breast epithelial cell lines, or RIE rat
we introduced a retroviral vector expressing hTERT into hFSintestinal epithelial cells (Hamad et al., 2002; Shields et al., 2000;
fibroblasts. In agreement with prior observations, introductionOldham et al., 1996). These data suggest that both species-
of hTERT rendered hFS fibroblasts immortalized, as they contin-and/or cell type-specific differences are likely to exist in the
ued to proliferate beyond P70 without any signs of growth retar-requirements of Ras-pathways for transformation.
dation (Figure 1B). In contrast, ectopic expression of mTERTWhile various studies indicate the existence of differences
into presenescent mouse fibroblasts did not prevent their earlyin the mechanisms of transformation of mouse and human cells,
entrance into senescence (Figure 1B), despite the induction ofnone has systematically enumerated these differences. Some
greatly enhanced telomerase activity (data not shown). Thus,studies have compared cells of the two species at different
the mechanisms controlling entrance into senescence of humanages, such as adult cells from one species versus embryonic
and mouse cells in culture appeared to be quite different, incells from the other. Yet other studies have been undertaken
that one was prevented by ectopic telomerase expression whileusing different cells originating in different tissues, such as fi-
the other was not.broblasts of one species versus epithelial cells of the other
(Drayton et al., 2003; Hamad et al., 2002; Oldham et al., 1996).
Escape from Ras-induced senescenceMoreover, different experimental methods have been employed
Although oncogenic Ras mediates transformation of immortal-to introduce foreign genes.
ized MEFs, its expression in either primary MEFs or humanIn the present study, we have attempted to overcome many
primary fibroblasts has been shown to cause a senescence-of these limitations. To do so, we have employed fibroblasts
like growth arrest (Serrano et al., 1997). The p53 and pRb tumororiginating from the same tissue compartment and of compara-
suppressor pathways have been shown to be intimately involvedble developmental ages in the two species. We also explored
in regulating this form of senescence; they are in turn regulatedthe requirements for transforming human cells derived from
by the Arf and Ink4a proteins, respectively, both of which aredistinct cell lineages. These studies indicate substantial differ-
encoded by the Ink4a/Arf locus (Sherr, 2001). MEFs lacking Arf
ences in the genetic elements required for cell transformation
or p53 (Harvey et al., 1993; Kamijo et al., 1997), but not Ink4a
in the two species and from different tissue compartments and
or Rb (Krimpenfort et al., 2001; Sage et al., 2000; Sharpless et al.,
suggest possible limitations of some rodent experimental sys- 2001), have been reported to evade Ras-induced senescence,
tems for modeling human cancer pathogenesis. whereas adult human fibroblasts lacking functional Ink4a (Huot
et al., 2002), but not p53 (Wei et al., 2001), avoid Ras-induced
Results senescence. This suggests that the p53 pathway plays a central
role in regulating Ras-induced senescence of murine cells, while
Species-specific differences regulate immortalization the Rb pathway appears to play the predominant role in human
In order to compare murine and human cellular requirements cells. Since escape from Ras-induced senescence is likely to
for transformation in a well-controlled way, we obtained very be essential for Ras-mediated cell transformation, we sought
early passage human dermal fibroblasts from newborn foreskin, to determine the respective roles of these two pathways in side-
hereafter referred to as hFS fibroblasts. To obtain tissue- and by-side comparisons of mNBS and hFS fibroblasts.
developmental stage-matched murine fibroblasts, we prepared To do so, we introduced retroviral vectors encoding SV40
dermal fibroblasts from the skin of newborn (day 3) male pups LT cDNA and its mutant derivatives into these two cell types.
of the C57/BL6 inbred mouse strain, which we term mNBS Wild-type LT binds to and inactivates both p53 and the family
fibroblasts. Since the restricted replication potential of human, of “pocket proteins” (i.e., pRb, p107, and p130). Its mutant
but not murine, primary cells in vitro has been suggested to derivative LTK1 binds and inactivates only p53, while another
represent a barrier to immortalization and transformation (New- mutant form LT434-444 binds and inactivates only the pocket
bold et al., 1982; Sager, 1991), we first compared the in vitro proteins (Hahn et al., 2002). We assessed the functional efficacy
long-term growth properties of these two types of cells. of the LT K1 mutant by measuring the p53-dependent upregula-
In keeping with prior observations made with mouse embry- tion of p21 protein in response to DNA damage, and that of
onic fibroblasts (MEFs) (Todaro and Green, 1963), mNBS fibro- LT434-444 by measuring E2F-activity in confluent cultures,
blasts grown in standard tissue culture conditions showed a and found it to be comparable in both mouse and human cells
widespread senescence-like phenotype (enlarged, flattened (data not shown).
morphology) and associated acidic -galactosidase enzyme ac- Since primary human fibroblasts differ from their murine
tivity by passage 6 (Figure 1A). After passage 8 (P8), however, counterparts in that they lack readily detectable endogenous
clones of spontaneously immortalized mouse fibroblasts began telomerase expression and activity, we reasoned that we should
to emerge (Figure 1B). In contrast, and also consistent with compare the requirements of primary hFS fibroblasts expressing
previous observations (Hayflick and Moorhead, 1961), hFS fi- ectopic hTERT and primary mNBS fibroblasts to escape Ras-
broblasts proceeded to proliferate until passage 53 (P53), when induced senescence.
they first showed signs of widespread replicative senescence We infected early passage primary mNBS fibroblasts with
(Figure 1). The senescent hFS fibroblasts remained in this retroviruses specifying the cDNAs of LT, LTK1, or LT434-444,
or alternatively with control retroviruses. Parallel cultures of earlygrowth-arrested state for prolonged periods of time (up to six
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Figure 1. Senescent and immortalization pheno-
types in primary mouse and human fibroblasts
A: Phase contrast photomicrographs (top panel)
and histochemical staining for SA--galactosi-
dase activity (bottom panel) of mNBS and hFS
fibroblasts at the indicated passage number. All
images are at the same magnification (scale
bar  100 m).
B: Long-term growth curves for mouse and hu-
man fibroblasts. Graphs show passage history of
mNBS and hFS fibroblasts in the absence (black
) or presence (green) of ectopic TERT expres-
sion. Cultures were passaged 1:4 at 80% con-
fluency. A brief plateau (arrow) can be seen in
mNBS cultures around passage 7, which indi-
cates the senescence phase. The senescence
phase in primary hFS fibroblasts is seen starting
at passage 53.
passage hFS fibroblasts were serially infected with one of the et al., 2000; Sharpless et al., 2001). However, we observed that
LT434-444-carrying murine cells also escaped Ras-inducedLT-encoding retroviruses followed by hTERT-encoding retrovi-
rus, and drug-resistant clones were selected. The resultant cells growth arrest, consistent with the behavior of triple knockout
MEFs (i.e., pRb/, p130/, p107/) (Sage et al., 2000). Takenwere subsequently infected with a retrovirus specifying onco-
genic V12 H-Ras (hereafter referred to as Ras) or a control together, these observations indicate that inactivation of either
p53 or the Rb family of pocket proteins enables murine fibro-retrovirus, and drug-resistant colonies were then selected. The
passage number of these cells following infection with Ras- blasts to evade Ras-induced senescence.
Consistent with prior reports (Wei and Sedivy, 1999), Rasencoding or corresponding control retrovirus is denoted as P.
Immunoblot analysis was performed at P1 to confirm ex- induced the senescence of hTERT-immortalized hFS fibro-
blasts, as assessed by change in morphology and SA--galac-pression of both LT and Ras proteins (Figure 2A). Very low
protein levels of the LT434-444 protein were detected in both tosidase activity (Figure 2B, right panel). It has been shown
previously that inactivation of either p53 or pRb alone is notmurine and human cells, consistent with prior observations indi-
cating that mutations in this domain of the protein render the sufficient to overcome Ras-induced senescence in human fi-
broblasts (Serrano et al., 1997), whereas inactivation of both ofprotein product metabolically unstable (Tevethia et al., 1988).
Introduction of the Ras-encoding vector resulted in a 10-fold these pathways allows escape from this growth arrest (Hahn et
al., 2002). In consonance with these results, we observed thatelevated oncogenic Ras expression compared to endogenous
Ras expression levels in both mouse and human cells (Fig- the hTERT- and LTK1- or LT434-444-expressing fibroblasts
showed senescence-like responses at P2 following introduc-ure 2A).
Like WT-MEFs (Serrano et al., 1997), primary mNBS fibro- tion of the ras oncogene, whereas LT-WT-expressing cells es-
caped (Figure 2B). However, by P4, the LTK1 and LT434-444blasts succumbed to Ras-induced senescence at P2 following
Ras infection and drug selection. These cells scored positive cultures that contained a high proportion of senescent cells
spontaneously gave rise to colonies of Ras-tolerant cells (Figurefor senescence-associated -galactosidase (SA--gal) activity,
whereas control retrovirus-infected cells did not (Figure 2B, left 2B, right panel). Immunoblot analysis confirmed that these colo-
nies continued to express greater than 10-fold elevated levelspanel). Similar to MEFs derived from Arf /or p53/ embryos,
the LTK1-expressing mNBS fibroblasts escaped Ras-induced of oncogenic Ras compared to endogenous Ras (Figure 2C).
Furthermore, immunoblot analysis revealed elevated expressiongrowth arrest (Figure 2B). It has previously been shown that
MEFs obtained from Ink4a/ or pRB/ embryos fail to recover levels of Ink4a in LTK1-expressing cells following Ras infection,
indicating that Ink4a downregulation did not play a role in thefrom Ras-induced growth arrest (Krimpenfort et al., 2001; Sage
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Figure 2. Effects of different LT mutants on Ras-induced senescence
A: Immunoblot analysis of large T antigen (LT) and Ras proteins expressed in mNBS and hFS fibroblasts. Primary fibroblasts were serially infected with
retroviruses specifying the different LT forms (LTK1, LT434-444 [lacking either the pRb or p53 binding domains, respectively], LT-WT, or SV40-ER [the cDNA
or genomic forms of large T antigen, respectively]), hTERT (in the case of hFS fibroblasts), and oncogenic Ras (Ras) or control viruses (V). The passage
number of cells following introduction of Ras or corresponding control vector is designated as P. Represented immunoblot analysis was undertaken
at P1.
B: Phase contrast or bright-field images of histochemical staining for SA--galactosidase activity in mNBS and hFS fibroblasts. Primary fibroblasts expressing
the different LT forms (LTK1, LT434-444, or LT-WT), hTERT (in the case of hFS fibroblasts), and oncogenic Ras (Ras) or control vector (V) were stained at P2
and P4. Scale bar  250 m.
C: Immunoblot analysis of Ras expressed in hFS fibroblasts. hTERT-expressing cells infected with a control retrovirus (V) or a retrovirus encoding oncogenic
Ras were analyzed at P6, and different forms of LT antigen (LTK1 or LT434-444) plus hTERT-expressing cells infected with a retrovirus encoding oncogenic
Ras were analyzed at P4.
D: Immunoblot analysis of endogenous Ink4a expressed in hFS fibroblasts. hTERT-expressing cells infected with a control retrovirus (V) or a retrovirus encoding
oncogenic Ras were analyzed at P1, and LTK1 (the mutant form of LT which does not bind pRb) plus hTERT-expressing cells infected with a retrovirus
encoding oncogenic Ras were analyzed at P1 and P4.
emergence of Ras-tolerant clones in LTK1-expressing cells (Fig- hTERT plates infected with Ras; nevertheless, Western blot
analysis revealed that these cells expressed low levels of ectopicure 2D). These results are consistent with a recent study demon-
strating that siRNA-mediated suppression of p53-expression in Ras compared to cells at P1 (Figures 2A and 2C), suggesting
the selection of clonal outgrowths of cells that managed to shuthuman BJ-hTERT fibroblasts enabled them to escape from Ras-
induced senescence (Voorhoeve and Agami, 2003). down Ras expression deriving from the retroviral vector. Taken
together, these data demonstrated that in both hFS-fibroblastsBy P6, clones of cells began to emerge even from hFS-
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Figure 3. Anchorage-independent growth and
tumorigenicity of Ras-expressing mNBS and hFS
fibroblasts
A: Soft agar colony formation of mNBS (left
panel) and hFS fibroblasts (right panel). Cells ex-
pressing different forms of the LT antigen, onco-
genic Ras (Ras) or vector control (V), and hTERT	
ST (in the case of hFS fibroblasts) were analyzed.
Figure shows representative photomicrographs
of colonies generated by mNBS cells seeded at
1 
 104 cells/plate and hFS cells seeded at 5 

104 cells/plate. Scale bar  500 m; last panel,
100 m.
B–D: Tumor growth curves formed by mNBS and
hFS fibroblasts. 2
 106 cells were injected subcu-
taneously into nude mice and tumor growth was
monitored. Graphs represent growth curves of
tumors formed by mNBS fibroblasts overexpress-
ing different forms of LT antigen (LTK1, LT434-444,
or LT-WT) and oncogenic Ras (open symbols) or
control vector (filled symbols, represented by )
(B). Growth curves of tumors formed by hFS fi-
broblasts overexpressing SV40-ERhTERTonco-
genic Ras (), or different forms of LT antigens
(LTK1, LT434-444, or LT-WT), hTERT, and onco-
genic Ras or control vector (represented by )
(C). Growth curves of tumors formed by mNBS
fibroblasts expressing either LT-WT (, the cDNA
form of LT) or SV40-ER (, the genomic fragment
of SV40 that specifies both LT and ST), and onco-
genic Ras (open symbols) or control vector (filled
symbols, represented by ) (D). In all tumor
growth curve experiments, the error bars repre-
sent mean tumor volume 	 SEM. The numbers in
parenthesis indicate number of tumors formed/
number of injection sites.
(expressing hTERT) and primary mNBS fibroblasts, the pres- Additional expression of mTERT did not further the transformed
phenotype of these cells (data not shown).ence of either LTK1 or LT434-444 enables escape from Ras-
induced senescence, indicating that inactivation of either p53 In the same experiment, however, Ras failed to elicit efficient
colony formation from hFS human fibroblasts expressing LTK1,or Rb-family proteins (pRb, p107, and p130) alone suffices to
enable escape from Ras-induced growth arrest in these human LT434-444, or LT-WT, together with, in all cases, hTERT (Fig-
ure 3A). Very small, microscopic clumps containing 5–10 cellscells. Thus, both mouse and human neonatal dermal fibroblasts
have essentially identical requirements for tolerating oncogenic were observed at a very low frequency compared to vector
control cells (data not shown). These cells also failed to formRas-expression.
tumors in mice (Figure 3C), indicating that inactivation of p53
or Rb family members alone or in concert is not sufficient forRequirements of SV40 functions
Ras-mediated transformation of human fibroblasts, even in thefor Ras-mediated transformation
presence of ectopically expressed hTERT.We next determined the transformation-related phenotypes of
We have previously demonstrated that hTERT-immortalizedthese Ras-expressing cells. Oncogenic Ras enabled mNBS fi-
human BJ fibroblasts require the additional actions of the smallbroblasts expressing LTK1, LT434-444, or WT LT to form large
T (ST) oncoprotein, along with loss of pRb and p53 functions,and robust colonies in soft agar with comparable efficiencies
to undergo Ras-mediated transformation (Hahn et al., 2002).(Figure 3A), while the empty vector-containing cells failed to
To test whether hFS fibroblasts also required ST functions forgenerate any colonies. Furthermore, when injected into mice
transformation, we serially introduced the SV40-early regionsubcutaneously, all cell types that generated anchorage-inde-
(which encodes both LT and ST; henceforth SV40-ER), hTERT,pendent colonies also formed tumors in vivo with comparable
and oncogenic ras into primary hFS fibroblasts. We additionallygrowth kinetics (Figure 3B). Thus, consistent with prior observa-
tions demonstrating that MEFs derived from p53- or pRb/p107/ introduced a retroviral vector encoding the cDNA version of ST
in trans in cells already expressing LTK1, LT434-444, or LTp130 null mice (Sage et al., 2000) can be transformed by onco-
genic Ras, our results demonstrated that inactivation of either together with hTERT. The resultant drug-resistant cells were
subjected to transformation assays.p53 or the family of pRb-related pocket proteins is sufficient
for Ras-mediated tumorigenesis of primary mouse fibroblasts. As anticipated, hFS fibroblasts expressing SV40-ER
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hTERTRas formed robust colonies in soft agar (Figure 3A) and (Figure 4A). Specific activation of downstream pathways by
different Ras effector mutants was verified as described in Fig-also generated tumors when injected subcutaneously into nude
ure 5 (data not shown).mice (Figure 3C). We observed that the SV40-ER-encoding ret-
We proceeded to determine which of these cell populationsrovirus resulted in higher expression of the LT oncoprotein
were capable of anchorage-independent growth. In contrast tocompared to the LT cDNA-encoding retrovirus (Figure 2A). Also,
control vector cells, mNBS fibroblasts expressing the S35 RasST-expressing human fibroblasts expressed higher levels of Ras
mutant and LT formed colonies with maximum efficiency,oncoprotein compared to non-ST expressing fibroblasts (Figure
whereas cells expressing G37 or C40 plus LT generated only2A). Nonetheless, introduction of ST in trans in hFS fibroblasts
a few, very small colonies (Figure 4B). When injected subcutane-already expressing LT-WThTERTRas resulted in efficient
ously into nude mice, the S35-expressing cells generated tu-colony formation (Figure 3A) and tumor growth (in all 6 out of
mors in 8 out of 9 injections, albeit with a slightly increased6 injections), thus confirming the essential role of ST in this
latency compared to cells expressing oncogenic Ras bearingtransformation.
a wild-type effector domain (Figure 4C). The G37-expressingIn the same experiment, introduction of ST in both LTK1
cells failed to initiate any tumors, while only 1 out of 9 injectionsand LT434-444 plus hTERT-expressing hFS cells resulted in
of the C40-expressing cells generated a small tumor. Thesethe generation of small and abortive colonies in contrast to the
observations indicate that activation of the Raf pathway alonelarge and robust colonies formed by SV40-ERhTERTRas
suffices for both anchorage-independent growth and in vivoexpressing cells (Figure 3A). These ST-expressing cells also
tumorigenicity of LT-immortalized mouse primary fibroblasts,failed to form tumors in mice (in all 6 out of 6 injections), demon-
consistent with prior studies performed in spontaneously im-strating that even though inactivation of either p53 or pRb-family
mortalized NIH3T3 MEFs (Campbell et al., 1998; Rodriguez-is sufficient to escape from Ras-induced growth arrest, neither
Viciana et al., 1997).of these changes, on its own, suffices for transformation to a
In contrast, none of the Ras effector loop mutants, whentumorigenic state.
expressed on its own, induced robust colony formation byTogether, these experiments demonstrated clearly that
SV40-ERhTERT-expressing human fibroblasts, although a lowhuman fibroblasts require the inactivation of both p53 and pRb-
number of small colonies was observed in cells expressing C40family plus expression of hTERT, ST, and Ras, whereas inactiva-
when compared to vector control cells (Figure 4B). These resultstion of either p53 or pRb-family members suffices for Ras-
contrast with those described in a recent report demonstratingmediated transformation of murine fibroblasts. Accordingly, five
the ability of SV40-ERhTERT-immortalized human BJ fibro-
alterations were required to transform human fibroblasts, while
blasts expressing only the G37 mutant to efficiently form anchor-
two were required for their murine counterparts.
age-independent colonies (Hamad et al., 2002). The reasons
for this discrepancy are unknown. On the basis of our experi-
Immortalized human fibroblasts require activation ments, we conclude that activation of any one of the three major
of Raf and Ral-GEFs for tumorigenic transformation Ras effector pathways, on its own, is insufficient to mediate
While acquisition of a mutant ras allele or introduction of a efficient anchorage-independent colony formation by SV40-
ras oncogene represents a single genetic alteration, the Ras ERhTERT-expressing hFS fibroblasts.
oncoprotein that results actually controls a number of distinct We next determined whether concurrent activation of any
downstream signaling pathways (Campbell et al., 1998; Shields two Ras-downstream pathways might cooperate in the transfor-
et al., 2000). We therefore sought to dissect the respective mation of human fibroblasts. To do so, we generated SV40-
contributions of these effector pathways to Ras-mediated trans- ERhTERT-expressing hFS fibroblasts carrying pairs of Ras
formation of mouse and human cells. The three Ras effector mutants (S35G37, S35C40, or G37C40) by introducing a
pathways known to play major roles in cellular transformation second Ras effector mutant expressed by a retroviral vector
have been shown to involve the Raf, PI3K, and Ral-GEF proteins encoding a different drug resistance marker. The expression
(Shields et al., 2000). In order to explore which of these pathways levels of Ras and Ras mutants generated by this vector were
is required for transformation of mouse and human fibroblasts, tested and found to be similar to those expressed in the previous
we employed effector-loop mutants of oncogenic Ras (Rodri- experiments from a different retroviral vector (data not shown).
guez-Viciana et al., 1997). These mutants are single amino- We observed that the pairwise expression of S35G37 and
acid substitutions in the effector loop domain of oncogenic V12 S35C40 into human fibroblasts enabled efficient colony for-
H-Ras that cause each of them to preferentially activate only mation, although not as robust as those induced by oncogenic
one of the three above-mentioned effector pathways. Thus, the Ras bearing the wild-type effector domain (Figure 4B). In con-
V12H-RasT35S mutant binds and activates Raf, but not PI3K or trast, the combination of G37C40 failed to generate robust
Ral-GEF, the V12H-RasE37G mutant binds and activates only Ral- colonies. When injected into nude mice, however, only those
GEFs, and the V12H-RasY40C mutant binds and activates only cells expressing the combination of S35G37 formed tumors
PI3K (Rodriguez-Viciana et al., 1997). These mutants of onco- in vivo, albeit with an increased latency when compared with the
genic Ras are hereafter referred to as S35, G37, and C40 respec- tumors induced by oncogenic Ras bearing a wild-type effector
tively. domain (Figure 4E). Cells expressing G37C40 formed 1 tumor
The cDNAs specifying these various Ras mutants were intro- out of 9 injections with a further increased latency. Taken together,
duced into LT-expressing cultures of mNBS fibroblasts and these results demonstrate that SV40-ERhTERT-immortalized
SV40-ERhTERT-expressing hFS fibroblasts. Polyclonal popu- human fibroblasts specifically require the activation of Raf and
lations of cells expressing the various Ras mutants were found Ral-GEF pathways for tumorigenicity, while activation of Raf alone
to express levels of H-Ras oncoprotein comparable to those was sufficient for transforming LT-immortalized murine fibro-
blasts.expressing oncogenic Ras with a wild-type effector domain
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Figure 4. Requirements of Ras pathways for
transforming mNBS and hFS fibroblasts
A: Immunoblot analysis of Ras protein expression
in mNBS fibroblasts overexpressing LTcDNA or
SV40-ER (which encodes both LT and ST) and hFS
fibroblasts overexpressing SV40-ERhTERT. These
cells were subsequently infected with control re-
troviruses (V), retroviruses encoding oncogenic
Ras (Ras), or individual Ras effector loop mutants
(S35, G37, or C40, which preferentially activate
Raf, Ral-GEFs, or PI3K, respectively).
B: Soft agar colony formation of mNBS (top
panel) and hFS fibroblasts (bottom panel). Mu-
rine fibroblasts overexpressing LT-WT or SV40-ER,
and oncogenic Ras, Ras effector loop mutants,
or vector control were analyzed. Similarly, hFS
fibroblasts overexpressing SV40-ER, hTERT and on-
cogenic Ras, control vector, or Ras effector loop
mutants (individually or in pairs) were analyzed.
Figure shows representative photomicrographs
of colonies generated by mNBS cells seeded at
1 
 104 cells/plate and hFS cells seeded at 5 

104 cells/plate.
C–E: Tumor growth curves formed by mNBS and
hFS fibroblasts. Graphs represent growth curves
of tumors formed by mNBS fibroblasts overex-
pressing LT-WT and oncogenic Ras (), S35 (),
G37, C40, or control vectors (represented by )
(C). Growth curves of tumors formed by mNBS
fibroblasts overexpressing SV40-ER and onco-
genic Ras (), S35 (O), G37 (), C40 (c), or control
vector () (D). Growth curves of tumors formed
by hFS fibroblasts overexpressing SV40-ERhTERT
and oncogenic Ras (), S35G37 (), G37C40,
S35C40, S35, G37, C40, or control vector (repre-
sented by ) (E).
Since the human fibroblasts used in these experiments addi- ally into these cells. We observed that the SV40-ER-expressing
murine fibroblasts formed colonies in soft agar at a low fre-tionally carried the ST oncogene compared with mouse fibro-
blasts, this raised the possibility that interaction of ST with the quency even without Ras (Figures 3A and 4B). Subsequent
introduction of any of the Ras mutants sufficed to cause robustRas pathways might somehow play a role in this observed dis-
crepancy. In order to address this issue, we generated murine and efficient transformation of these cells, comparable to that
seen with cells expressing oncogenic Ras bearing a wild-typefibroblasts expressing the SV40-ER (which encodes both LT
and ST) and then introduced each of the Ras mutants individu- effector domain (Figure 4B). Additionally, in contrast to cells
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Figure 5. Requirements of Ras pathways for
transforming immortalized human embryonic
kidney (HEK) cells
A: Immunoblot analysis of Ras protein expressed
in SV40-ERhTERT- immortalized HEK cells, HA1Es.
HA1E cells were infected with control retrovirus
(V), retrovirus encoding oncogenic Ras (Ras), or
the indicated Ras effector loop mutants (S35,
G37, or C40, which preferentially activate Raf,
Ral-GEFs, or PI3K, respectively).
B: Soft agar colony formation of HA1E cells ex-
pressing control vector (V), oncogenic Ras (Ras),
or indicated Ras-effector loop mutants. Figure
shows representative photomicrographs of HA1E
cells seeded at 5 
 104 cells/plate.
C: Immunoblot analysis of phospho-MAPK pro-
teins expressed in serum-starved HA1E cells
(grown in 0.1% IFS containing media for 4 hr) ex-
pressing control vector (V), oncogenic Ras, or
indicated Ras effector loop mutants.
D: Immunoblot analysis of phospho-Akt and total
Akt proteins expressed in serum starved and ma-
trix-detached HA1E cells expressing control vec-
tor (V), oncogenic Ras (Ras), or indicated Ras
effector loop mutants.
E: GTP-Ral pull down assay in HA1E cells express-
ing control vector (V), oncogenic Ras (Ras), indi-
cated Ras effector loop mutants, or a constitu-
tively active form of Rlf (Rlf*, a Ral-GEF family
member).
F: Soft agar colony formation of HA1E cells ex-
pressing control vector (V) or constitutively ac-
tive forms (*) of Rlf (Rlf-CAAX) and Akt (myr-Akt),
alone or together. 5
 104 cells were seeded per
plate in triplicates and total number of colonies
generated were counted with an automated
colony counter (Gel-doc system; UVP Inc.)
Graph shows mean 	 SD of one representative
experiment.
G: Soft agar colony formation of Ras-expressing
HA1E (HA1ER) cells. Colonies formed by HA1ER
cells expressing control vector or a dominant-
negative (DN) form of Ral (RalN28) (i). Colonies
formed by HA1ER cells in the presence of DMSO
or PI3K inhibitor LY294002 (10 M in DMSO) (ii).
H: Tumor growth curves formed by HA1E cells
overexpressing Ras (), G37C40 (), S35G37,
S35C40, S35, G37, C40, or control vector (repre-
sented by ).
expressing the control vector, all of the cell lines expressing any pared to LT-expressing cells, data not shown) and the ex-
pressed Ras effector loop mutant. Alternatively, ST may contrib-single Ras mutant formed tumors in nude mice with comparable
growth kinetics (Figure 4D). ute to transformation by mechanisms independent of, and
complementary to, Ras signaling. Very recently it has beenThese data demonstrated that in mNBS fibroblasts express-
ing LT, only expression of S35 led to successful transformation shown that ST can stabilize c-Myc, and that a stabilized mutant
of c-Myc can replace ST in transforming human cells (Yeh et(Figure 4B and 4C), whereas in mNBS fibroblasts expressing
ER (LTST), expression of any single Ras effector loop mutant al., 2004).
Thus, immortalized mNBS fibroblasts minimally requiredresulted in transformation (Figures 4B and 4D). This may, in
part, be explained by cooperation between the slightly elevated only S35 expression for transformation (Figures 4B and 4C),
whereas ERhTERT-immortalized hFS cells failed to be trans-MAPK activity detected in the ER-expressing mNBS cells (com-
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Table 1. Species- and cell type-specific requirements for tumorigenic transformation
Inactivation Activation
Cell types p53 pRb family TERT ST Raf PI3K Ral-GEF
Mouse fibroblasts       
      
Human fibroblasts       
Human embryonic kidney cells       
Human mammary epithelial cells       
Based on readouts obtained in Figures 2–6, this table summarizes the requirements for tumorigenic conversion of mouse fibroblasts, human fibroblasts,
human embryonic kidney cells, and human mammary epithelial cells. These variations may ultimately reflect quantitative rather than qualitative differences
in biological responses.
formed by expression of any single Ras effector loop mutant. Similar to the observed responses of human fibroblasts,
activation of any one Ras effector pathway failed to mediateWhile coexpression of S35 and G37 or C40 into ERhTERT
containing hFS cells gave rise to colony formation in vitro, only anchorage-independent growth of HA1E cells in vitro (Figure
5B). These results again contrast with those described in athe combination of S35 and G37 formed tumors in nude mice
(Figures 4B and 4E). One possible reason why S35 expression recent report demonstrating the ability of SV40-ERhTERT-
immortalized HEK cells expressing only the G37 mutant to effi-alone sufficed for mNBS transformation could be that the basal
activity of the Ral-GEF and PI3K activity is higher in mNBS ciently form anchorage-independent colonies (Hamad et al.,
2002). The reasons for this discrepancy are unknown and mayfibroblasts. If this were so, then LT-expressing mNBS fibroblasts
should, on their own, show colony formation in soft agar, since derive from the use of cells that had been propagated in culture
extensively before their genetic manipulation.cooperation between Ral-GEF and PI3K pathway has previously
been shown to transform murine fibroblasts (Rodriguez-Viciana We then introduced a second Ras mutant into these cells,
and resultant cells were subjected to soft agar analysis. Weet al., 1997). However, we failed to detect any soft agar colony
formation in LT-expressing mNBS cells (Figure 3A). Further- observed that only the specific combination of G37 and C40
mediated robust and efficient anchorage-independent growth,more, we failed to detect any difference in the basal activity of
the Ral-GEF and PI3K pathway between mNBS and hFS cells comparable to those formed by oncogenic Ras bearing a wild-
type effector binding domain (Figure 5G). This demonstrated(data not shown).
Taken together, these and the earlier experiments demon- that immortalized HEK cells require specific activation of Ral-
GEFs and PI3K, but not Raf, for transformation in vitro as gaugedstrated that while perturbation of two signaling pathways involv-
ing p53 and Raf sufficed for the tumorigenic transformation of by anchorage-independent growth. Thus, whereas activation of
the Raf  Ral-GEF or the Raf  PI3K effectors was requirednewborn murine fibroblasts, transformation of human foreskin
fibroblasts required the perturbation of these two pathways plus for the anchorage-independent growth of human fibroblasts,
at least four additional pathways, involving Rb, hTERT, PP2A, specific activation of PI3K and Ral-GEFs was required for the
and Ral-GEFs (Table 1). same outcome in human embryonic kidney cells.
In order to rule out the contribution of direct or indirect
activation of additional Ras-pathways by the various Ras ef-Activation of PI3K and Ral-GEFs is both necessary
and sufficient for tumorigenic transformation fector-loop mutants, we measured the biochemical responses
evoked by each of these mutants. We monitored the levels ofof immortalized human embryonic kidney cells
The cell physiologic actions of the various Ras effector pathways phospho-ERK1/2 and Akt, which act as good indicators of the
activation of Raf and PI3K pathway, respectively. In order tohave usually been defined in the context of fibroblasts. However,
emerging evidence suggests that there may be cell type-specific measure the activation of Ral-GEFs, we measured the activation
of their downstream component Ral by performing GTP-Raldifferences in the requirements of Ras effectors for cellular
transformation (Hamad et al., 2002; Shields et al., 2000). We pulldown assays. These data confirmed that distinct Ras mu-
tants indeed activated specific downstream effector pathwaystherefore assessed the requirement of the Ras effector path-
ways in the transformation of human embryonic kidney cells (Figures 5C–5E).
To further confirm that activation of PI3K plus Ral-GEFs is(HEKs), which originate from the embryonic mesoderm and pos-
sess both mesenchymal and epithelial characteristics. sufficient for transforming HA1E cells, we introduced constitu-
tively active components of these two pathways into immortal-We previously found that HEK cells can be immortalized
by the introduction of the SV40-ER and a construct encoding ized HA1E cells. Thus, concomitant expression of a constitu-
tively active mutant of Akt and Rlf (a Ral-GEF family member;hTERT, and that such immortalized cells can then be trans-
formed by expression of a Ras oncoprotein (Hahn et al., 1999). Rlf-CAAX) enabled anchorage-independent colony formation in
HA1E cells, whereas individually they failed to do so (FigureThus, these immortalized HEK cells, termed HA1Es (Hahn et
al., 1999), offer a good system to dissect the requirements of 5F). Furthermore, inhibition of PI3K using a chemical inhibitor,
LY294002, or inhibition of the Ral-pathway via a dominant-Ras signaling for transformation. We introduced the three Ras
mutants into these cells individually, confirmed high levels of negative mutant of Ral inhibited colony formation in Ras-trans-
formed HA1E cells (Figure 5G). Taken together, these resultsexpression of each Ras mutant by Western blotting (Figure 5A),
and thereafter assessed their transformation behavior. confirmed that the activation of the P13K and Ral-GEF pathways
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Figure 6. Requirements of Ras pathways for
transforming immortalized human mammary ep-
ithelial cells
A: Immunoblot analysis of Ras protein expressed
in SV40-ERhTERT immortalized HMECs (HMLEs).
HMLE cells were infected with control retroviruses
(V), retroviruses encoding oncogenic Ras (Ras),
or indicated Ras effector loop mutants (S35, G37,
or C40, which preferentially activate Raf, Ral-
GEFs, or PI3K, respectively).
B: Soft agar colony formation of HMLE cells ex-
pressing control vector (V), oncogenic Ras (Ras),
or indicated Ras-effector loop mutants. Figure
shows representative photomicrographs of cells
seeded at 2 
 105 cells/plate.
C: Tumor growth curves formed by HMLE cells
expressing oncogenic Ras (), G37C40 (O),
S35G37 (c), S35C40 (), S35, G37, C40, or con-
trol vector (represented by ).
is both sufficient and necessary for in vitro transformation of pathways by the various Ras effector loop mutants (data not
immortalized HA1E cells. shown), we sought to determine the transformation potential of
We next determined whether expression of G37 and C40 these various HMLE cells.
also sufficed for tumor formation. To this end, we introduced While introduction of S35 and C40 alone, but not G37, gener-
HA1E cells expressing the Ras mutants, either singly or in pairs, ated soft agar colonies when compared to vector control cells,
into nude mice. Only the combination of G37 and C40 yielded their numbers were low when compared to those induced by
tumors in nude mice, although with an increased latency com- oncogenic Ras bearing a wild-type effector domain (Figure 6B).
pared to that of cells expressing oncogenic Ras bearing a wild- When a second, distinct Ras effector mutant was introduced
type effector loop domain (Figure 5H). into these cells, all the pairwise combinations formed colonies.
Taken together, these experiments demonstrate that con- However, the colonies were still fewer in number than those
current activation of PI3K and Ral-GEFs is both sufficient and induced by oncogenic wild-type Ras acting on its own (Figure
necessary for the Ras-mediated tumorigenic transformation of 6B). To be more precise, the combination of S35 and C40 formed
immortalized human embryonic kidney cells, in contrast to the colonies more efficiently than did the other two pairwise combi-
requirement of Raf and Ral-GEFs needed for the tumorigenic nations. When these various cells were introduced into nude
conversion of human fibroblasts (Table 1). mice, none of the cells expressing the effector mutants either
singly or in pair-wise combinations generated tumors in vivo
Tumorigenic transformation of immortalized human (Figure 6C).
mammary epithelial cells requires activation In order to exclude the possibility that reduced levels of
of Raf, PI3K, and Ral-GEFs mutant Ras proteins were responsible for the failure to transform
Since Ras mutations are commonly associated with epithelial these immortalized HMECs to tumorigenic derivatives, we intro-
tumors (Bos, 1989), we further assessed the requirements of duced the S35 mutant of Ras into HMLE cells that were already
Ras-effector pathways in the transformation of one frequently
expressing both the G37 and C40 effector loop mutants ofstudied type of human epithelial cell—human mammary epithe-
oncogenic Ras. The resultant HMLE cells concomitantly ex-lial cells (HMECs). We have previously demonstrated that intro-
pressing all three Ras effector-loop mutants efficiently formedduction of SV40-ER and hTERT into HMECs immortalizes them
robust colonies that were larger than those created by the Ras(Elenbaas et al., 2001). Subsequent expression of supraphysio-
oncoprotein carrying a wild-type effector domain (Figure 6B).logical levels of oncogenic Ras caused these cells to undergo
This demonstrated that the individual Ras mutants, when ex-tumorigenic conversion (Elenbaas et al., 2001). Accordingly,
pressed singly or in pairs, were indeed being expressed at levelsthese immortalized HMECs, hereafter referred to as HMLEs,
that were compatible with efficient transformation. Thus, theserepresented a useful reagent to assess the requirements for Ras
results indicated that activation of all three major componentseffector signaling in epithelial cell transformation. We therefore
of Ras signaling pathways was essential for the tumorigenicintroduced retroviral vectors specifying the three Ras mutants
transformation of human mammary epithelial cells, further dem-into HMLE cells. Western blot analysis revealed that the levels
onstrating that different human cell types indeed have distinctof Ras effector loop mutants being expressed were comparable
requirements of Ras effector pathways for transformationto that of oncogenic Ras bearing a wild-type effector domain
(Figure 6A). After confirming specific activation of downstream (Table 1).
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Discussion gether with the present results demonstrating differential re-
quirements of Ras-effector pathways for transformation of cells
from distinct tissue types (Table 1), may explain why certain Ras-The extensive use of mouse models of human cancer pathogen-
esis has yielded a wealth of insights into the mechanistic details oncoproteins are frequently associated with tumors of certain
tissues (Downward, 2003).of tumor progression in humans. Nonetheless, the great evolu-
tionary distance separating humans and mice has led to sub- In addition to differences in the requirements of Ras path-
ways for transformation of different cell types, other cell type-stantial differences in the biology of these two mammalian spe-
cies (Rangarajan and Weinberg, 2003). Some of these divergent specific variations have also been observed. For example, while
expression of the catalytic domain of human telomerase alonebiological features might well reside at the level of individual
cells and at the subcellular circuits governing various aspects suffices to immortalize human fibroblasts and endothelial cells,
human mammary epithelial cells and keratinocytes additionallyof cell behavior, including the processes of oncogenic transfor-
mation. require inactivation of the p16/Rb pathway (Hahn and Weinberg,
2002a). At present, it is unclear whether these differences inThe present observations demonstrate that profound differ-
ences do indeed exist in the mechanisms of experimental trans- requirements for immortalization reflect fundamental differences
in cell biology (that may also affect transformation), or simplyformation of cultured human and murine fibroblasts. Nonethe-
less, these findings have intrinsic limitations. Our comparisons differing requirements for survival in tissue culture.
Multiple chemotherapeutic drugs targeting the Ras path-are influenced by the particular identities of the cell types being
studied, and we could well imagine that other pairs of human- ways have been generated that fare well in preclinical trials
performed in mouse xenograft models; however, the clinicalmouse cell populations prepared from tissues not examined in
the present work might exhibit greater or lesser differences than responses observed in early stage human trials have not been
encouraging (Downward, 2003). If the signaling pathways cru-the pairs of cells analyzed here. Moreover, these differences
might well not apply to the cells of all inbred strains of mice cial for tumor initiation and maintenance are different for cells
of different species, and even for diverse cell types within theand to those of wild mice. In spite of these caveats, we conclude
that interspecies differences in the biology of cell transformation same species, then it is only natural that drugs targeting specific
pathways will be more effective for certain tumors than for oth-are substantial, and that they may compromise or confound
attempts at relating the behaviors of mouse and human cells ers. This underscores the great need to precisely elucidate the
requirements of various human cell types for tumorigenic trans-during tumor progression.
The potential relevance of these in vitro findings to in vivo formation as a prerequisite to developing truly effective antican-
cer therapies. The present work, which has attempted to sys-tumorigenesis in humans is indicated by the observations that
most of the alterations described here as being essential for tematically analyze the signaling requirements of cells from
different human cell types (fibroblasts, embryonic kidney cells,transforming human cells in vitro are similar or identical to those
encountered in commonly occurring human tumors. For exam- and mammary epithelial cells), indicates that the intrinsic biologi-
cal differences between various cell types must be taken intople,90% of human tumors have acquired telomerase activity,
and the remainder appear to employ alternate telomere length- account when attempting to extrapolate responses of one cell
type to those of another.ening mechanisms (ALT) (Shay, 1997), indicating that telomere
maintenance is a crucial event in tumor progression and that
Experimental procedureshuman cancer cells must acquire this function. In addition, the
SV40 LT antigen binds and inactivates two major cellular tumor
Vectors
suppressor proteins pRb and p53; alterations of the two regula- Individual Ras effector loop mutants from pSG5 vector (Rodriguez-Viciana
tory circuits controlled by these two proteins are observed in et al., 1997) were subcloned into pBABEpuro, pWZL blast, and pBABE-
most and perhaps all types of human adult malignancies (Hana- Zeo retroviral vectors. The Bgl2-EcoR1 fragment of Rlf-CAAX (described in
Wolthuis et al., 1997) and EcoR1 fragment of Ral-N28 (described in Uranohan and Weinberg, 2000; Sherr and McCormick, 2002).
et al., 1996) were subcloned into pWZL-Blast. Other constructs have beenThe SV40 ST oncoprotein binds and inhibits some isoforms
described previously (Elenbaas et al., 2001; Hahn et al., 2002).of a major cellular serine-threonine phosphatase, PP2A (Jans-
sens and Goris, 2001). It has recently been demonstrated that Virus production, infection, and cell lines
suppression of PP2A B56 expression could replace ST in trans- Amphotropic retroviruses were produced by transient transfection of 293T
formation of HEK cells (Chen et al., 2004), thereby suggesting cells with a retroviral vector and amphotropic packaging plasmid pCL-10A1
that ST-mediated inactivation of this specific subunit is critical (Imgenex), or packaging plasmids encoding pCMV-VSV-G and pUMVC3-
gag-pol (Aldevron) separately using Fugene 6 (Roche Molecular Biochemi-for human cell transformation. Whether suppression of this com-
cals). Both mouse and human cells at 25% confluency were infected forponent of PP2A action also occurs frequently in spontaneously
4 hr with viral supernatants containing 8 g/ml polybrene. Typically 80%arising human cancers remains to be demonstrated.
infection efficiency was achieved using this protocol, as assessed by parallel
Three members of the Ras gene family—H-Ras, K-Ras, and infections of GFP-encoding virus. After infection, fresh media was supple-
N-Ras—are found to be activated by mutation in 30% of all mented, and two days following infection, drug selection was initiated. Neo-
human tumors (Shields et al., 2000). Even though these various mycin, blasticidin, hygromycin, puromycin, and zeocin were used at 400, 4,
0.3, 1, and 200 g/ml for mNBS fibroblasts, and at 1500, 6, 0.3, 1, and 500Ras proteins bind to all the three major Ras-effectors involved
g/ml for hFS fibroblasts.in transformation, differences in the efficacy with which different
Ras family proteins activate specific downstream effectors have
Cells and culture conditionbeen demonstrated (Yan et al., 1998). For example, K-Ras has
Primary mouse fibroblasts were obtained from newborn pups of C57/BL6
been shown to bind and activate Raf much more efficiently than inbred mouse strain by overnight trypsinization of the skin followed by colla-
H-Ras, while H-Ras has been shown to activate PI3K more genase treatment, and grown in standard tissue culture conditions of 5%
CO2 and 20% O2 and passaged at 1:4 when80% confluent. Primary humanefficiently than K-Ras (Yan et al., 1998). These data, taken to-
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determines sensitivity of human cells to transformation by cooperating cellu-foreskin (hFS) fibroblasts were obtained from the Cell Culture Core Facility
lar oncogenes. Cancer Cell 4, 301–310.of Yale Skin Disease Research Center and cultured in DME  10% IFS.
Each passage corresponds to 2 population doublings. HA1E and HMLE Elenbaas, B., Spirio, L., Koerner, F., Fleming, M.D., Zimonjic, D.B., Donaher,
culture conditions were described in Hahn et al. (1999) and Elenbaas et al. J.L., Popescu, N.C., Hahn, W.C., and Weinberg, R.A. (2001). Human breast
(2001). cancer cells generated by oncogenic transformation of primary mammary
epithelial cells. Genes Dev. 15, 50–65.
Immunoblotting and immunoprecipitation
Hahn, W.C., and Weinberg, R.A. (2002a). Modelling the molecular circuitryProtein expression was measured by immunoblotting 40–80 g of total
of cancer. Nat. Rev. Cancer 2, 331–341.proteins with antibodies specific to-actin (Abcam, Cambridge, United King-
dom), phospho-Akt and phospho-p44/42 ERK (New England Biolabs), and Hahn, W.C., and Weinberg, R.A. (2002b). Rules for making human tumor
human p16-Ink4a (Pharmingen). For phospho-Akt detection, 1 
 105 HEK cells. N. Engl. J. Med. 347, 1593–1603.
cells were resuspended in 0.1% serum-containing media and seeded in a
Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks,60 mm tissue culture plate precoated with polyhydroxy-ethylmethacrylate
M.W., and Weinberg, R.A. (1999). Creation of human tumour cells with(10 mg/ml, SIGMA). For Ral-activation assay, HEK cells were serum starved
defined genetic elements. Nature 400, 464–468.
for 4 hr, and processed using the Ral-Activation kit (Upstate).
Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini,
D.M., DeCaprio, J.A., and Weinberg, R.A. (2002). Enumeration of the simianSA--galactosidase assay
virus 40 early region elements necessary for human cell transformation. Mol.Cells were fixed with 0.2% glutaraldehyde (Sigma) and incubated in a filtered
Cell. Biol. 22, 2111–2123.solution containing 1 mg/ml X-Gal (Sigma) in 150 mM NaCl, 2 mM MgCl2,
5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, and 40 mM sodium phosphate buffer Hamad, N.M., Elconin, J.H., Karnoub, A.E., Bai, W., Rich, J.N., Abraham,
(pH 6.0). R.T., Der, C.J., and Counter, C.M. (2002). Distinct requirements for Ras
oncogenesis in human versus mouse cells. Genes Dev. 16, 2045–2057.
Anchorage-independent growth assay
Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100,Soft agar assays were performed as described in Hahn et al., 1999. Individual
57–70.cell lines were seeded in triplicates at three different dilutions ranging be-
tween 1 
 103 and 5 
 105. Each experiment was repeated at least once. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M.E., Wiseman, R.W., Pantazis,
Colonies were photographed between 18–24 days at a final magnification P., Giovanella, B.C., Tainsky, M.A., Bradley, A., and Donehower, L.A. (1993).
of 20
 under phase contrast microscope. In vitro growth characteristics of embryo fibroblasts isolated from p53-defi-
cient mice. Oncogene 8, 2457–2467.
Tumorigenicity assay
Hayflick, L., and Moorhead, P.S. (1961). The serial cultivation of human6- to 8-week-old nude mice were subcutaneously injected with 2 
 106 cells
diploid cell strains. Exp. Cell Res. 25, 585–621.
admixed with 15% Matrigel (Becton Dickinson, Palo Alto, California). HMLE
cells were admixed with 50% Matrigel. In all tumor growth curve experiments, Huot, T.J., Rowe, J., Harland, M., Drayton, S., Brookes, S., Gooptu, C.,
Purkis, P., Fried, M., Bataille, V., Hara, E., et al. (2002). Biallelic mutationsthe error bars represent mean tumor volume 	 SEM. The numbers in paren-
in p16(INK4a) confer resistance to Ras- and Ets-induced senescence inthesis indicate number of tumor formed/number of injection sites.
human diploid fibroblasts. Mol. Cell. Biol. 22, 8135–8143.
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